Ticker name:INSM INSMED Inc
Country: US-Sector: Healthcare, Industry: Biotechnology
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.
- CEO: William H. Lewis
- IPO: Jun 01, 2000
- Website:insmed.com (open a new tab)
Market Cap 23B
Last close 107.91$
Key metrics
Largest 20 companies In Biotechnology
| # Position | Ticker | Company Name | Market Cap | Last Price | Action |
|---|---|---|---|---|---|
| 1 | VRTX | VERTEX PHARMACEUTICALS INC / MA | 109B | 430.44$ | |
| 2 | REGN | REGENERON PHARMACEUTICALS, INC. | 68B | 649.76$ | |
| 3 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | 40B | 298.48$ | |
| 4 | RVMD | Revolution Medicines, Inc. | 32B | 150.33$ | |
| 5 | RPRX | Royalty Pharma plc | 31B | 53.06$ | |
| 6 | UTHR | UNITED THERAPEUTICS Corp | 24B | 563.93$ | |
| 7 | INSM | INSMED Inc | 23B | 107.91$ | |
| 8 | ROIV | Roivant Sciences Ltd. | 23B | 32.41$ | |
| 9 | INCY | INCYTE CORP | 19B | 97.08$ | |
| 10 | MRNA | Moderna, Inc. | 19B | 48.12$ | |
| 11 | GMAB | GENMAB A/S | 17B | 27.21$ | |
| 12 | JAZZ | Jazz Pharmaceuticals plc | 15B | 239.01$ | |
| 13 | ASND | Ascendis Pharma A/S | 15B | 241.34$ | |
| 14 | SMMT | Summit Therapeutics Inc. | 14B | 17.89$ | |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13B | 68.22$ | |
| 16 | EXEL | EXELIXIS, INC. | 13B | 49.9$ | |
| 17 | IONS | IONIS PHARMACEUTICALS INC | 12B | 75.06$ | |
| 18 | AXSM | Axsome Therapeutics, Inc. | 12B | 230.62$ | |
| 19 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | 12B | 513.47$ | |
| 20 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 11B | 77.14$ |